tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
URGN
Urogen Pharma
RESEARCH TOOLSreports

Urogen Pharma (URGN) Stock News & Sentiment

Compare
653 Followers
UroGen Pharma’s Promising Outlook: Buy Rating Backed by ZUSDURI’s Growth and Strong Financial Health
Premium
Ratings
UroGen Pharma’s Promising Outlook: Buy Rating Backed by ZUSDURI’s Growth and Strong Financial Health
2M ago
URGN
UroGen Pharma’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
UroGen Pharma’s Earnings Call: Growth Amid Challenges
2M ago
URGN
UroGen Pharma’s ZUSDURI Launch Drives Q3 Growth
Premium
Company Announcements
UroGen Pharma’s ZUSDURI Launch Drives Q3 Growth
2M ago
URGN
Urogen Pharma’s Promising Growth and Demand Surge Support Buy Rating
Premium
Ratings
Urogen Pharma’s Promising Growth and Demand Surge Support Buy Rating
2M ago
URGN
UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment
Premium
Company Announcements
UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment
2M ago
URGN
UroGen Pharma’s Phase 3 Study on UGN-103: A Potential Game-Changer in Bladder Cancer Treatment
Premium
Company Announcements
UroGen Pharma’s Phase 3 Study on UGN-103: A Potential Game-Changer in Bladder Cancer Treatment
2M ago
URGN
Urogen Pharma’s Jelmyto Registry: Real-World Insights into UTUC Treatment
Premium
Company Announcements
Urogen Pharma’s Jelmyto Registry: Real-World Insights into UTUC Treatment
2M ago
URGN
More URGN News >

URGN News on the Web

Why UroGen Pharma Ltd.’s (URGN) Stock Is Up 5.66%
AAII
Neutral
Why UroGen Pharma Ltd.’s (URGN) Stock Is Up 5.03%
AAII
Neutral
UroGen Pharma Grants 32,500 Inducement RSUs to Support Expansion of Oncology Commercialization Team
Market Chameleon
Neutral
Why UroGen Pharma Ltd.’s (URGN) Stock Is Down 5.34%
AAII
Neutral
Why UroGen Pharma Ltd.’s (URGN) Stock Is Down 5.73%
AAII
Neutral
Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates
Zacks
Neutral
UroGen’s UTOPIA Trial Shows 77.8% Response Rate: FDA Greenlights Path for UGN-103 Submission
Market Chameleon
Neutral
Why UroGen Pharma Ltd.’s (URGN) Stock Is Up 6.13%
AAII
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is URGN’s Media Buzz Sentiment?
Currently, no data Available
What is URGN’s weekly average amount of articles?
Currently, no data Available
What is URGN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
DVAXDynavax
AGIOAgios Pharma
PDEXPro-Dex
EWTXEdgewise Therapeutics
ATAIATAI Life Sciences
Showing the stocks with the most bullish news sentiment over the past week